Aerie raises $125M via pair of offerings

Ophthalmic company Aerie Pharmaceuticals Inc. (NASDAQ:AERI) raised a combined $125 million in a follow-on and at-the-market offering. Cantor Fitzgerald is managing both. The company raised $75 million through the sale of 1.4 million shares at $53.75 per share in an upsized follow-on. It also raised $50 million via an at-the-market share sale filed before market hours Thursday.

The follow-on's price is a 1% discount to Aerie's close of $54.25 on Thursday, when it proposed to raise $50 million after market close. Aerie priced the follow-on before market hours Friday, and gained $1.65 to $55.90 on Friday...